By Melanie Barnard
Category: Investigational Triple-Hormone Receptor Agonist
Developer: Eli Lilly & Co.
Primary Focus: Weight loss, metabolic health, type 2 diabetes
Retatrutide is the newest and most advanced peptide in the GLP-1 class, designed as a triple agonist, meaning it activates three key hormone receptors: GLP-1, GIP, and glucagon. These receptors play major roles in controlling appetite, blood sugar, and energy expenditure.
Retatrutide is being called the “next-generation” of semaglutide (Ozempic) and tirzepatide (Mounjaro) — offering even greater weight-loss potential.
Mechanism of Action
Retatrutide acts on:
Together, these create a synergistic effect, helping the body burn fat while controlling hunger and stabilizing glucose.
In a Phase 2 clinical trial published in The New England Journal of Medicine, participants lost up to 24% of total body weight in 48 weeks — one of the most significant results ever reported for a medication of this type.
Improvements were also seen in blood sugar control, liver fat reduction, and cholesterol levels.
Side effects were similar to other GLP-1-based drugs: nausea, vomiting, diarrhea, but generally well-tolerated after dose adjustment.
Category: Regenerative Peptide
Origin: Derived from a protective protein found in the human stomach
Primary Focus: Tissue repair, inflammation reduction, recovery
BPC-157 is a naturally occurring healing peptide found in gastric juices. It has been shown in numerous animal studies to speed up tissue regeneration, repair muscle and tendon damage, and reduce inflammation.
Often referred to as the “healing peptide,” it’s popular among biohackers, athletes, and regenerative medicine clinics — though it remains unapproved for medical use in humans.
BPC-157 promotes healing through several pathways:
This helps accelerate recovery from soft tissue damage, tendinitis, and surgical wounds.
Rodent studies show accelerated healing of tendons, ligaments, bone, and intestinal tissue.
Neuroprotective effects: may help repair nerve injury and reduce brain inflammation.
Gut healing: protective effects in colitis, leaky gut, and stomach ulcer models.
No major human trials have yet been completed — evidence remains preclinical.
Category: Regenerative / Repair Peptide
Origin: Synthetic fragment of thymosin beta-4, a natural protein found in human and animal tissues
Primary Focus: Cell regeneration, injury recovery, inflammation reduction
TB-500 is a synthetic version of a portion of Thymosin Beta-4, a peptide naturally present in almost all human cells. It helps regulate actin — a protein essential for cell structure and movement — making it key in wound healing and tissue remodeling.
It’s widely used in regenerative and sports medicine for faster recovery after injuries, surgeries, or intense physical strain.
TB-500 works by:
Together, these actions enhance healing speed and tissue flexibility.
Animal models: improved healing in tendon and muscle injuries, heart tissue repair post-heart attack.
May reduce scar tissue formation and improve flexibility of healed tissue.
Human data: limited to anecdotal or small case reports.
Combined with BPC-157, results may be synergistic — enhancing overall healing response.
As with all unregulated peptides, product purity and contamination risk are concerns
